Roles of macrophages in formation and progression of intracranial aneurysms

doi:10.3785/j.issn.1008-9292.2019.04.13

J Zhejiang Univ (Med Sci)

2019, Vol. 48

Issue (2): 204-213 DOI: 10.3785/j.issn.1008-9292.2019.04.13

Roles of macrophages in formation and progression of intracranial aneurysms

WANG Yaqi(

),JIN Jinghua*(

)

Department of Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China

Download:

HTML( 22 )

PDF(995KB)
Export: BibTeX | EndNote (RIS)

Abstract

Studies have shown that chronic inflammatory response plays a key role in intracranial aneurysms (IA) formation and progression, and macrophages regulate the formation and progression of IA through a variety of pathways. Bone marrow monocyte-derived macrophages and resident-tissue macrophages infiltrate the vessel wall, after infiltration macrophages are polarized into various polarization phenotypes dominated by M1-like and M2-like cells. Polarized phenotypes of macrophages can regulate the formation and progression of intracranial aneurysms by releasing cytokines and regulating the inflammatory response of other immune cells, as well as release different cytokines to regulate the process of extracellular matrix remodeling. Some important progresses have been made in the clinical detection and treatment in targeting macrophages. This review provides a summary on the pathogenesis of IA and potential drug targets to prevent the formation and rupture of intracranial aneurysms.

Key words： Macrophages/pathology Intracranial aneurysm/pathology Inflammation Tumor necrosis factor-alpha/secretion Matrix metalloproteinases Immunity, cellular Nuclear factor-kappa B

Received: 20 November 2018 Published: 24 July 2019

CLC:

R363

Corresponding Authors: JIN Jinghua E-mail: 21618530@zju.edu.cn;jhjin@zju.edu.cn

	Service
	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Yaqi
	JIN Jinghua

Cite this article:

WANG Yaqi,JIN Jinghua. Roles of macrophages in formation and progression of intracranial aneurysms. J Zhejiang Univ (Med Sci), 2019, 48(2): 204-213.

URL:

http://www.zjujournals.com/med/10.3785/j.issn.1008-9292.2019.04.13 OR http://www.zjujournals.com/med/Y2019/V48/I2/204

巨噬细胞在颅内动脉瘤发生发展中的作用研究进展

大量研究表明慢性炎性反应是颅内动脉瘤（IA）形成和破裂的核心环节，作为IA病变中最多见的炎症细胞，巨噬细胞通过多种途径调控IA的发生、发展。骨髓来源单核细胞分化而来的巨噬细胞及组织固有巨噬细胞浸润血管壁；浸润后的巨噬细胞受不同刺激极化为以M1型和M2型巨噬细胞为主的各类极化表型；各种极化表型的巨噬细胞既能通过释放细胞因子和调控其他免疫细胞调控炎性反应，也能释放不同细胞因子作用于细胞外基质重塑过程，从而调控颅内动脉瘤的发生、发展。临床上，以巨噬细胞为靶点的检测和治疗手段已取得一定进展。本文为深入理解IA发病机制和寻找阻止颅内动脉瘤形成和破裂的药物治疗提供理论依据。

关键词： 巨噬细胞/病理学, 颅内动脉瘤/病理学, 炎症, 肿瘤坏死因子α/分泌, 基质金属蛋白酶类, 免疫, 细胞, 核因子κB

Fig 1 Possible mechanism of macrophage in the process of formation and rupture of intracranial aneurysms

Fig 2 Polarization mechanism of macrophages based on NF-κB signaling pathway


[1]	VLAK M H , ALGRA A , BRANDENBURG R et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period:a systematic review and meta-analysis[J]. Lancet Neurol, 2011, 10 (7): 626- 636 doi: 10.1016/S1474-4422(11)70109-0

[2]	DE ROOIJ N K , LINN F H , VAN DER PLAS J A et al. Incidence of subarachnoid haemorrhage:a systematic review with emphasis on region, age, gender and time trends[J]. J Neurol Neurosurg Psychiatry, 2007, 78 (12): 1365- 1372 doi: 10.1136/jnnp.2007.117655

[3]	WIEBERS D O , WHISNANT J P , HUSTON J et al. Unruptured intracranial aneurysms:natural history, clinical outcome, and risks of surgical and endovascular treatment[J]. Lancet, 2003, 362 (9378): 103- 110 doi: 10.1016/S0140-6736(03)13860-3

[4]	FR?SEN J , PⅡPPO A , PAETAU A et al. Remodeling of saccular cerebral artery aneurysm wall is associated with rupture:histological analysis of 24 unruptured and 42 ruptured cases[J]. Stroke, 2004, 35 (10): 2287- 2293 doi: 10.1161/01.STR.0000140636.30204.da

[5]	AOKI T , KATAOKA H , MORIMOTO M et al. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats[J]. Stroke, 2007, 38 (1): 162- 169

[6]	KANEMATSU Y , KANEMATSU M , KURIHARA C et al. Critical roles of macrophages in the formation of intracranial aneurysm[J]. Stroke, 2011, 42 (1): 173- 178

[7]	SHIMADA K , FURUKAWA H , WADA K et al. Protective role of peroxisome proliferator-activated receptor-γ in the development of intracranial aneurysm rupture[J]. Stroke, 2015, 46 (6): 1664- 1672 doi: 10.1161/STROKEAHA.114.007722

[8]	SHAKUR S F , ALARAJ A , MENDOZA-ELIAS N et al. Hemodynamic characteristics associated with cerebral aneurysm formation in patients with carotid occlusion[J]. J Neurosurg, 2018, 1- 6

[9]	ZHANG X , YAO Z Q , KARUNA T et al. The role of wall shear stress in the parent artery as an independent variable in the formation status of anterior communicating artery aneurysms[J]. Eur Radiol, 2019, 29 (2): 689- 698 doi: 10.1007/s00330-018-5624-7

[10]	EPELMAN S , LAVINE K J , RANDOLPH G J . Origin and functions of tissue macrophages[J]. Immunity, 2014, 41 (1): 21- 35 doi: 10.1016/j.immuni.2014.06.013

[11]	DAVIES L C , JENKINS S J , ALLEN J E et al. Tissue-resident macrophages[J]. Nat Immunol, 2013, 14 (10): 986- 995 doi: 10.1038/ni.2705

[12]	GAUTIER E L , SHAY T , MILLER J et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages[J]. Nat Immunol, 2012, 13 (11): 1118- 1128 doi: 10.1038/ni.2419

[13]	SCHULZ C , GOMEZ P E , CHORRO L et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells[J]. Science, 2012, 336 (6077): 86- 90 doi: 10.1126/science.1219179

[14]	HASHIMOTO D , CHOW A , NOIZAT C et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes[J]. Immunity, 2013, 38 (4): 792- 804 doi: 10.1016/j.immuni.2013.04.004

[15]	FANG P , LI X , DAI J et al. Immune cell subset differentiation and tissue inflammation[J]. J Hematol Oncol, 2018, 11 (1): 97

[16]	XUE J , SCHMIDT S V , SANDER J et al. Transcriptome-based network analysis reveals a spectrum model of human macrophage activation[J]. Immunity, 2014, 40 (2): 274- 288 doi: 10.1016/j.immuni.2014.01.006

[17]	HASAN D , CHALOUHI N , JABBOUR P et al. Macrophage imbalance (M1 vs. M2) and upregulation of mast cells in wall of ruptured human cerebral aneurysms:preliminary results[J]. J Neuroinflammation, 2012, 9:222

[18]	ZHANG H F , ZHAO M G , LIANG G B et al. Dysregulation of CD4(+) T cell subsets in intracranial aneurysm[J]. DNA Cell Biol, 2016, 35 (2): 96- 103 doi: 10.1089/dna.2015.3105

[19]	THOMAS A J , OGILVY C S , GRIESSENAUER C J et al. Macrophage CD163 expression in cerebrospinal fluid:association with subarachnoid hemorrhage outcome[J]. J Neurosurg, 2018, 1- 7

[20]	NOWICKI K W , HOSAKA K , WALCH F J et al. M1 macrophages are required for murine cerebral aneurysm formation[J]. J Neurointerv Surg, 2018, 10 (1): 93- 97 doi: 10.1136/neurintsurg-2016-012911

[21]	AOKI T , KATAOKA H , SHIMAMURA M et al. NF-kappaB is a key mediator of cerebral aneurysm formation[J]. Circulation, 2007, 116 (24): 2830- 2840 doi: 10.1161/CIRCULATIONAHA.107.728303

[22]	THEUS M H , BRICKLER T , MEZA A L et al. Loss of NLRX1 exacerbates neural tissue damage and NF-κB signaling following brain injury[J]. J Immunol, 2017, 199 (10): 3547- 3558 doi: 10.4049/jimmunol.1700251

[23]	AOKI T , FRO`` SEN J , FUKUDA M et al. Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms[J]. Sci Signal, 2017, 10 (465): pii:eaah6037 doi: 10.1126/scisignal.aah6037

[24]	LUO D , GUO Y , CHENG Y et al. Natural product celastrol suppressed macrophage M1 polarization against inflammation in diet-induced obese mice via regulating Nrf2/HO-1, MAP kinase and NF-κB pathways[J]. Aging(Albany NY), 2017, 9 (10): 2069- 2082

[25]	HUANG F , ZHAO J L , WANG L et al. miR-148a-3p mediates notch signaling to promote the differentiation and M1 activation of macrophages[J]. Front Immunol, 2017, 8:1327 doi: 10.3389/fimmu.2017.01327

[26]	YANG Q W , MOU L , LV F L et al. Role of Toll-like receptor 4/NF-kappaB pathway in monocyte-endothelial adhesion induced by low shear stress and ox-LDL[J]. Biorheology, 2005, 42 (3): 225- 236

[27]	NISHIMURA M . Toll-like receptor 4 expression during cerebral aneurysm formation[J]. J Neurosurg, 2013, 119 (3): 825- 827 doi: 10.3171/2013.6.JNS09329a

[28]	KURKI M I , HAKKINEN S K , FROSEN J et al. Upregulated signaling pathways in ruptured human saccular intracranial aneurysm wall:an emerging regulative role of Toll-like receptor signaling and nuclear factor-κB, hypoxia-inducible factor-1A, and ETS transcription factors[J]. Neurosurgery, 2011, 68 (6): 1667- 1676 doi: 10.1227/NEU.0b013e318210f001

[29]	BUCHANAN M M , HUTCHINSON M , WATKINS L R et al. Toll-like receptor 4 in CNS pathologies[J]. J Neurochem, 2010, 114 (1): 13- 27

[30]	AOKI T , NISHIMURA M , MATSUOKA T et al. PGE(2)-EP(2) signalling in endothelium is activated by haemodynamic stress and induces cerebral aneurysm through an amplifying loop via NF-κB[J]. Br J Pharmacol, 2011, 163 (3): 1237- 1249

[31]	IKEDO T, MINAMI M, KATAOKA H, et al. Dipeptidyl peptidase-4 inhibitor anagliptin prevents intracranial aneurysm growth by suppressing macrophage infiltration and activation[J/OL]. J Am Heart Assoc, 2017, 6(6): pii: e004777.

[32]	NAHRENDORF M , SWIRSKI F K . Abandoning M1/M2 for a network model of macrophage function[J]. Circ Res, 2016, 119 (3): 414- 417 doi: 10.1161/CIRCRESAHA.116.309194

[33]	GOSSELIN D , LINK V M , ROMANOSKI C E et al. Environment drives selection and function of enhancers controlling tissue-specific macrophage identities[J]. Cell, 2014, 159 (6): 1327- 1340 doi: 10.1016/j.cell.2014.11.023

[34]	JAYARAMAN T , BERENSTEIN V , LI X et al. Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms[J]. Neurosurgery, 2005, 57 (3): 558- 564 doi: 10.1227/01.NEU.0000170439.89041.D6

[35]	ZHANG H F , ZHAO M G , LIANG G B et al. Expression of pro-inflammatory cytokines and the risk of intracranial aneurysm[J]. Inflammation, 2013, 36 (6): 1195- 1200 doi: 10.1007/s10753-013-9655-6

[36]	STARKE R M , CHALOUHI N , JABBOUR P M et al. Critical role of TNF-α in cerebral aneurysm formation and progression to rupture[J]. J Neuroinflammation, 2014, 11:77 doi: 10.1186/1742-2094-11-77

[37]	AOKI T , FUKUDA M , NISHIMURA M et al. Critical role of TNF-alpha-TNFR1 signaling in intracranial aneurysm formation[J]. Acta Neuropathol Commun, 2014, 2:34 doi: 10.1186/2051-5960-2-34

[38]	ALI M S , STARKE R M , JABBOUR P M et al. TNF-α induces phenotypic modulation in cerebral vascular smooth muscle cells:implications for cerebral aneurysm pathology[J]. J Cereb Blood Flow Metab, 2013, 33 (10): 1564- 1573 doi: 10.1038/jcbfm.2013.109

[39]	MORIWAKI T , TAKAGI Y , SADAMASA N et al. Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice[J]. Stroke, 2006, 37 (3): 900- 905 doi: 10.1161/01.STR.0000204028.39783.d9

[40]	AOKI T , KATAOKA H , ISHIBASHI R et al. Reduced collagen biosynthesis is the hallmark of cerebral aneurysm:contribution of interleukin-1beta and nuclear factor-kappaB[J]. Arterioscler Thromb Vasc Biol, 2009, 29 (7): 1080- 1086 doi: 10.1161/ATVBAHA.108.180760

[41]	WKE I , HOSHI N , SHOUVAL D S et al. Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages[J]. Science, 2017, 356 (6337): 513- 519 doi: 10.1126/science.aal3535

[42]	CHEN J , YANG L , CHEN Y et al. Controlled release of osteopontin and interleukin-10 from modified endovascular coil promote cerebral aneurysm healing[J]. J Neurol Sci, 2016, 360:13- 17 doi: 10.1016/j.jns.2015.11.037

[43]	MARTINEZ F O , GORDON S . The M1 and M2 paradigm of macrophage activation:time for reassessment[J]. F1000Prime Rep, 2014, 6:13

[44]	ITALIANI P , BORASCHI D . From monocytes to M1/M2 macrophages:phenotypical vs. functional differentiation[J]. Front Immunol, 2014, 5:514

[45]	ISHIBASHI R , AOKI T , NISHIMURA M et al. Contribution of mast cells to cerebral aneurysm formation[J]. Curr Neurovasc Res, 2010, 7 (2): 113- 124 doi: 10.2174/156720210791184916

[46]	SHI J , JOHANSSON J , WOODLING N S et al. The prostaglandin E2 E-prostanoid 4 receptor exerts anti-inflammatory effects in brain innate immunity[J]. J Immunol, 2010, 184 (12): 7207- 7218 doi: 10.4049/jimmunol.0903487

[47]	LIU J , KUWABARA A , KAMIO Y et al. Human mesenchymal stem cell-derived microvesicles prevent the rupture of intracranial aneurysm in part by suppression of mast cell activation via a PGE2-dependent mechanism[J]. Stem Cells, 2016, 34 (12): 2943- 2955 doi: 10.1002/stem.v34.12

[48]	XU J , MA F , YAN W et al. Identification of the soluble form of tyrosine kinase receptor Axl as a potential biomarker for intracranial aneurysm rupture[J]. BMC Neurol, 2015, 15:23 doi: 10.1186/s12883-015-0282-8

[49]	ETMINAN N , DREIER R , BUCHHOLZB A et al. Age of collagen in intracranial saccular aneurysms[J]. Stroke, 2014, 45 (6): 1757- 1763 doi: 10.1161/STROKEAHA.114.005461

[50]	CAIRD J , NAPOLI C , TAGGART C et al. Matrix metalloproteinases 2 and 9 in human atherosclerotic and non-atherosclerotic cerebral aneurysms[J]. Eur J Neurol, 2006, 13 (10): 1098- 1105 doi: 10.1111/ene.2006.13.issue-10

[51]	JIN D , SHENG J , YANG X et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases expression in human cerebral ruptured and unruptured aneurysm[J]. Surg Neurol, 2007, 68 Suppl 2:S11- S16

[52]	NUKI Y , TSOU T L , KURIHARA C et al. Elastase-induced intracranial aneurysms in hypertensive mice[J]. Hypertension, 2009, 54 (6): 1337- 1344 doi: 10.1161/HYPERTENSIONAHA.109.138297

[53]	AOKI T , KATAOKA H , MORIWAKI T et al. Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms[J]. Stroke, 2007, 38 (8): 2337- 2345 doi: 10.1161/STROKEAHA.107.481838

[54]	KILIC T , SOHRABIFAR M , KURTKAYA O et al. Expression of structural proteins and angiogenic factors in normal arterial and unruptured and ruptured aneurysm walls[J]. Neurosurgery, 2005, 57 (5): 997- 1007 doi: 10.1227/01.NEU.0000180812.77621.6C

[55]	MOREL S , DIAGBOUGA M R , DUPUY N et al. Correlating clinical risk factors and histological features in ruptured and unruptured human intracranial aneurysms:the Swiss AneuX Study[J]. J Neuropathol Exp Neurol, 2018, 77 (7): 555- 566 doi: 10.1093/jnen/nly031

[56]	AOKI T , KATAOKA H , NISHIMURA M et al. Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-kappaB and Ets with chimeric decoy oligodeoxynucleotide treatment[J]. Neurosurgery, 2012, 70 (6): 1534- 1543 doi: 10.1227/NEU.0b013e318246a390

[57]	TURJMAN A S , TURJMAN F , EDELMAN E R . Role of fluid dynamics and inflammation in intracranial aneurysm formation[J]. Circulation, 2014, 129 (3): 373- 382 doi: 10.1161/CIRCULATIONAHA.113.001444

[58]	CHALOUHI N , HOH B L , HASAN D . Review of cerebral aneurysm formation, growth, and rupture[J]. Stroke, 2013, 44 (12): 3613- 3622 doi: 10.1161/STROKEAHA.113.002390

[59]	HASAN D M , MAHANEY K B , BROWN R D et al. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture[J]. Stroke, 2011, 42 (11): 3156- 3162 doi: 10.1161/STROKEAHA.111.619411

[60]	HASAN D M, CHALOUHI N, JABBOUR P, et al. Evidence that acetylsalicylic acid attenuates inflammation in the walls of human cerebral aneurysms: preliminary results[J/OL]. J Am Heart Assoc, 2013, 2(1): e000019.

[61]	GARCíA-RODRíGUEZ L A , GAIST D , MORTON J et al. Antithrombotic drugs and risk of hemorrhagic stroke in the general population[J]. Neurology, 2013, 81 (6): 566- 574 doi: 10.1212/WNL.0b013e31829e6ffa

[62]	HASAN D , CHALOUHI N , JABBOUR P et al. Early change in ferumoxytol-enhanced magnetic resonance imaging signal suggests unstable human cerebral aneurysm:a pilot study[J]. Stroke, 2012, 43 (12): 3258- 3265 doi: 10.1161/STROKEAHA.112.673400

[1]	MA Jing, HE Wenlong, GAO Chongyang, YU Ruiyun, XUE Peng, NIU Yongchao. Glucosides of chaenomeles speciosa attenuate ischemia/reperfusion-induced brain injury by regulating NF-κB P65/TNF-α in mouse model[J]. J Zhejiang Univ (Med Sci), 2019, 48(3): 289-295.

[2]	DING Jingjing,LU Yunbi. Research progress on receptor interacting proteins in inflammation[J]. J Zhejiang Univ (Med Sci), 2018, 47(1): 89-96.

[3]	LIU Yinlan,LUO Yan,YANG Wenjun,SHI Junping,ZHUANG ZhenJie. Effect of diammonium glycyrrhizinate and phospholipids complex oninflammatory gene expression induced by palmitic acid[J]. J Zhejiang Univ (Med Sci), 2017, 46(2): 192-197.

[4]	WANG Cheng, WANG Wenjun, YANG Wei, YU Xiaohua, YAN Yiguo, ZHANG Jian, JIANG Zhisheng. MicroRNAs: a type of novel regulative factor for intervertebral disc degeneration[J]. J Zhejiang Univ (Med Sci), 2016, 45(2): 170-178.

[5]	ZOU Xiao-rong, TAO Jian, WANG Yun-kai. Gap junction and diabetic foot[J]. J Zhejiang Univ (Med Sci), 2015, 44(6): 684-688.

[6]	LI Yu-ying, DING Yue-min, ZHANG Xiong. Progress on matrix metalloproteinase in axonal regeneration[J]. J Zhejiang Univ (Med Sci), 2015, 44(1): 95-100.

[7]	WU Lian-qun, LU Min. Efficacy of epigallocatechin gallate in treatment of alkali burn injury of murine cornea[J]. J Zhejiang Univ (Med Sci), 2015, 44(1): 15-23.

[8]	ZHANG Jian, ZHAO Zheng-yan. Research advances on immunoregulation and antiinflammation function of mesenchymal stem cells and their application in treatment of renal diseases[J]. J Zhejiang Univ (Med Sci), 2014, 43(3): 372-378.

[9]	SONG Shun-de， TANG Hui-fang . Progress in PDE4 targeted therapy for inflammatory diseases[J]. J Zhejiang Univ (Med Sci), 2014, 43(3): 353-358.

[10]	HUANG Jing, WEI Er-qing, LU Yun-bi . Research advances on the roles of nicotinamide phosphoribosyltransferase in inflammation[J]. J Zhejiang Univ (Med Sci), 2014, 43(2): 234-239.

[11]	. Characteristic of microglial activation of hippocampus in experimental epileptic rats[J]. J Zhejiang Univ (Med Sci), 2012, 41(3): 310-314.

[12]	. Role of microglial activation induced by α-synuclein in pathogenesis of Parkinson′s disease[J]. J Zhejiang Univ (Med Sci), 2012, 41(2): 210-214.

[13]	. Expression of high mobility group box chromosomal protein 1 in mice with lupus nephritis[J]. J Zhejiang Univ (Med Sci), 2011, 40(2): 200-206.

[14]	. Role of thermoTRP channels in cutaneous neurogenic inflammation and itch[J]. J Zhejiang Univ (Med Sci), 2009, 38(4): 409-414.

Viewed

Full text

Abstract

Cited

Shared

Discussed